Pseudomonas cepacia colonization in patients with cystic fibrosis: Risk factors and clinical outcome

The Journal of Pediatrics

Volumn 107, Issue 3, 1985, Pages 382-387

  Tablan, Ofelia C ^a,b   Chorba, Terence L ^a,b   Schidlow, Daniel V ^a,b   White, John W ^a,b   Hardy, Karen A ^a,b   Gilligan, Peter H ^a,b   Morgan, W Meade ^a,b   Carson, Loretta A ^a,b   Martone, William J ^a,b   Jason, Janine M ^a,b   Jarvis, William R ^a,b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BURKHOLDERIA CEPACIA; CHILD; CLINICAL ARTICLE; CONGENITAL DISORDER; CYSTIC FIBROSIS; DIAGNOSIS; HUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RISK; THERAPY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PATIENT ADMISSION; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; RISK;

EID: 0022005357     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(85)80511-4     Document Type: Article

References (36)

1. Cystic fibrosis
2. Perspectives in cystic fibrosis
3. Research in cystic fibrosis
4. Research in cystic fibrosis
5. Research in cystic fibrosis
6. The flora of the respiratory tract of patients with cystic fibrosis of the pancreas
7. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis
8. Pseudomonas colonization in cystic fibrosis—a study of 160 patients
9. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem
10. The role of Pseudomonas cepacia in pulmonary disease of cystic fibrosis patients
11. Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital
12. Long-term study of 105 patients with cystic fibrosis: studies made over 5–14 year period
13. Rapid identification of non-fermentative gram-negative rods by the Corning N/F system
14. Identification of pseudomonas and related bacteria
15. The Vitek AMS gram-negative identification (GNI) test kit
16. CDC guideline for prevention of nosocomial pneumonia
17. Pseudomonas cepacia: Implications and control of epidemic nosocomia colonization
18. Lung abscess due to Pseudomonas cepacia
19. Pneumonia and septicemia due to P. cepacia in a patient with cystic fibrosis
20. Pseudomonas cepacia pneumonia
21. P cepacia in the respiratory flora of patients with cystic fibrosis
22. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin
23. Moxalactam-tobramycin resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis
24. Applied pharmacokinetics in acute exacerbations of Pseudomonas aeruginosa pneumonia in cystic fibrosis
25. Is anti-pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?
26. Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo treatment
27. Commentary
28. A double-blind controlled trial of antipseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis
29. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis
30. Pseudomonas cepacia and cystic fibrosis: evidence for lack of person to person transmission
31. Pseudomonas cepacia and maltophilia in the cystic fibrosis patient
32. Characterization of Psuedomonas cepacia isolates from patients with cystic fibrosis